104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain

Artículo original

Año: 2021

Pereyra-Rodriguez, JJ; Dominguez-Cruz, J; Armario-Hita, JC; Ruiz-Villaverde, R

Título: ANAIS BRASILEIROS DE DERMATOLOGIA

• Q3